China approves Sinopharm's COVID-19 vaccine, prepares to inoculate all citizens with free shots

China granted authorization to Sinopharm's COVID-19 vaccine Dec. 31, approving its first state-developed COVID-19 vaccine for use in the general public, CNN reported.

The approval comes one day after the drugmaker said its vaccine is 79.34 percent effective in preventing COVID-19, citing interim analysis of phase 3 clinical trials.

Chinese citizens will be provided free vaccinations, Zeng Yixin, vice minister of China's National Health Commission, said during a Dec. 31 news conference. The country is seeking to inoculate 50 million people with domestically developed COVID-19 vaccines before February's Lunar New Year festivities, according to CNN.

 


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

Thank you so much for your interest in our content. Please register to access this complimentary archived content.

 

 

Already Registered? Click here to confirm.